1260657-19-9 Usage
Uses
Used in Pharmaceutical Drug Synthesis:
8-bromoquinazolin-4-amine is used as a building block for the synthesis of pharmaceutical drugs, contributing to the development of new medicinal compounds with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 8-bromoquinazolin-4-amine is utilized as a starting material for the development of innovative drugs, leveraging its chemical properties and biological activity to create novel therapeutic agents.
Used in Materials Science:
8-bromoquinazolin-4-amine is employed in the field of materials science, particularly for the development of organic semiconductors and optoelectronic devices, where its unique chemical structure and properties can enhance the performance and functionality of these advanced materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1260657-19-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,6,5 and 7 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1260657-19:
(9*1)+(8*2)+(7*6)+(6*0)+(5*6)+(4*5)+(3*7)+(2*1)+(1*9)=149
149 % 10 = 9
So 1260657-19-9 is a valid CAS Registry Number.
1260657-19-9Relevant academic research and scientific papers
2,4-DIARYL - SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER
-
Paragraph 0372; 0373, (2013/05/08)
The present invention relates to novel [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particu
2,4- DIARYL-SUBSTITUTED [1,8] NAPHTHYRIDINES AS KINASE INHIBITORS FOR USE AGAINST CANCER
-
Page/Page column 86, (2012/01/14)
The present invention relates to novel [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases playsa role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors
